In the context of a three-stage model with consumers differing in their health insurance coverage, the paper shows that there exist conditions under which the price of brand-name drugs increases following the entry of generic drugs.

In the case of persistent dumping, welfare effects are ambiguous. Therefore, the existing international trade theory cannot provide a clear rationale for policies to prohibit international price discrimination. Through a two-stage game on the endogenous foreign monopolist's dumping decision,...

The price premium of generic pharmaceuticals to brand-names is examined under different competitive market situations. The result of this study shows that the number, market share, and the age of both brand-name and generic products have the most explanatory power for explaining the price...

The objective of this paper is to provide two-stage game models explaining the 'Generic Competition Paradox' that demonstrates an increase of brand-name drug price in response to generic entry. Under the assumption that there are two groups of consumers who are segmented by their insurance...

The objective of this paper is to demonstrate that price dispersion is possible even in a world of perfect information and identical consumers and firms. The driving force in the model is service capacity and congestion cost. Each firm chooses a service capacity. Customers of a firm bear a...

In the literature explanations of price dispersion invariably depend on the assumptions of imperfect information and/or some form of heterogeneity among either consumers or firms. The objective of this paper is to demonstrate that price dispersion is possible even in a world of perfect...

This paper examines incentives for brand-name pharmaceutical producers to market pseudo-generic versions of their own branded products upon the expiry of patent protection.Using a two-stage game model, we determine that under plausible demand and cost conditions, brand-name incumbents can find...